Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription

Articles published in
JAMA Intern Med
    May 2024
  1. MAKHNEVICH A, Perrin A, Talukder D, Liu Y, et al
    Thick Liquids and Clinical Outcomes in Hospitalized Patients With Alzheimer Disease and Related Dementias and Dysphagia.
    JAMA Intern Med. 2024 May 6:e240736. doi: 10.1001/jamainternmed.2024.0736.
    >> Share

  2. REUBEN DB, Kremen S, Maust DT
    Dementia Prevention and Treatment: A Narrative Review.
    JAMA Intern Med. 2024;184:563-572.
    >> Share

    October 2023
    Chatbot Confabulations Are Not Hallucinations-Reply.
    JAMA Intern Med. 2023;183:1177-1178.
    >> Share

    July 2023
  4. MOLCHAN S, Fugh-Berman A
    Are New Alzheimer Drugs Better Than Older Drugs?
    JAMA Intern Med. 2023 Jul 31. doi: 10.1001/jamainternmed.2023.3061.
    >> Share

    June 2022
  5. WOLOSHIN S, Kesselheim AS
    What to Know About the Alzheimer Drug Aducanumab (Aduhelm).
    JAMA Intern Med. 2022 Jun 6. pii: 2792897. doi: 10.1001/jamainternmed.2022.1039.
    >> Share

    March 2022
  6. PALAN LOPEZ R, Hendricksen M, McCarthy EP, Mazor KM, et al
    Association of Nursing Home Organizational Culture and Staff Perspectives With Variability in Advanced Dementia Care: The ADVANCE Study.
    JAMA Intern Med. 2022;182:313-323.
    >> Share

    February 2022
  7. LEE CS, Gibbons LE, Lee AY, Yanagihara RT, et al
    Association Between Cataract Extraction and Development of Dementia.
    JAMA Intern Med. 2022;182:134-141.
    >> Share

    December 2021
  8. LARGENT EA, Peterson A, Lynch HF
    FDA Drug Approval and the Ethics of Desperation.
    JAMA Intern Med. 2021;181:1555-1556.
    >> Share

    October 2021
  9. CROSSON FJ, Covinsky K, Redberg RF
    Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?
    JAMA Intern Med. 2021;181:1278-1280.
    >> Share

    July 2021
    The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease.
    JAMA Intern Med. 2021 Jul 13. pii: 2782122. doi: 10.1001/jamainternmed.2021.4622
    >> Share

  11. DUNN B, Stein P, Cavazzoni P
    Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective.
    JAMA Intern Med. 2021 Jul 13. pii: 2782119. doi: 10.1001/jamainternmed.2021.4607
    >> Share

  12. MITCHELL SL, D'Agata EMC, Hanson LC, Loizeau AJ, et al
    The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.
    JAMA Intern Med. 2021 Jul 12. pii: 2782003. doi: 10.1001/jamainternmed.2021.3098
    >> Share

    November 2020
  13. NICHOLAS LH, Langa KM, Bynum JPW, Hsu JW, et al
    Financial Presentation of Alzheimer Disease and Related Dementias.
    JAMA Intern Med. 2020 Nov 30. pii: 2773241. doi: 10.1001/jamainternmed.2020.6432
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016